Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials

This publication has 21 references indexed in Scilit:

• Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
  The Annals of Thoracic Surgery, 2001
• Perioperative Predictors of ICU and Hospital Costs in Coronary Artery Bypass Graft Surgery
  Chest, 2000
• Stroke after coronary artery operation: incidence, correlates, outcome, and cost
  The Annals of Thoracic Surgery, 2000
• Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty
  American Heart Journal, 1999
• Clinical and Economic Impact of Diabetes Following Coronary Artery Bypass
  Journal of Surgical Research, 1998
• Operative Outcome And Hospital Cost
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
  The Annals of Thoracic Surgery, 1996
• A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
  Circulation, 1995
• Aprotinin for coronary bypass operations: Efficacy, safety, and influence on early saphenous vein graft patency
  The Journal of Thoracic and Cardiovascular Surgery, 1994
• Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
  The Annals of Thoracic Surgery, 1992